• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Seals key in new Ypsomed insulin pump

November 14, 2016 By Sarah Faulkner

Seals key in new Ypsomed insulin pumpSwiss medtech company Ypsomed (SWX:YPSN) launched a portable, light-weight insulin pump with seals designed by Freudenberg Sealing Technologies. The pump, mylife YpsoPump, was introduced into the European market today.

Insulin pumps, which continually transport insulin into patients, must have a very precise dosing mechanism. To facilitate a reliable measurement within the pump, there must be as little friction as possible among all the pump drive’s components. However, there must be enough of a seal between components that the device is protected from particles of dirt or water.

Freudenberg Sealing Technologies used a combination of seals and high-performance lubricant from Klüber Lubrication, a member of the Freudenberg Group, to solve this problem. The rod seal within the pump has a smooth, low-friction surface. Using nanotechnology, Freudenberg Sealing Technologies was able to reduce roughness and create even torque progression.

A perfluorinated polyether oil lubricant was used to cut low frictional torque in half. These lubricants are very stable compared to conventional lubricants and are even used in extreme conditions like space flight.

“Without the combination of an innovative sealing solution and the right lubricant, we would not have reached our goal,” René Mathys, who led the development of infusion systems at Ypsomed, said in prepared remarks.

Production the pump has begun in Switzerland and the 1st patients in the Netherlands, the U.K. and Germany have been carrying them for a few months. Each pump is limited to 4 years of use, which amounts to 35,000 hours of operation, according to Freudenberg.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Freudenberg Sealing Technologies, Ypsomed

IN CASE YOU MISSED IT

  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Go-Pen ApS wins FDA nod for user-filled insulin pen

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS